AU2001237254A1 - Lowering serum lipids - Google Patents

Lowering serum lipids

Info

Publication number
AU2001237254A1
AU2001237254A1 AU2001237254A AU3725401A AU2001237254A1 AU 2001237254 A1 AU2001237254 A1 AU 2001237254A1 AU 2001237254 A AU2001237254 A AU 2001237254A AU 3725401 A AU3725401 A AU 3725401A AU 2001237254 A1 AU2001237254 A1 AU 2001237254A1
Authority
AU
Australia
Prior art keywords
serum lipids
lowering serum
subject
lowering
lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237254A
Inventor
Liselotte Bjerre Knudsen
Philip Just Larsen
Johan Selmer
Jeppe Sturis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159299&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001237254(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2001237254A1 publication Critical patent/AU2001237254A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Abstract

The present invention relates to a method for lowering serum lipids, eg. triglycerides and/or cholesterol in a subject comprising administering a GLP-1 agonist to said subject.
AU2001237254A 2000-03-08 2001-03-08 Lowering serum lipids Abandoned AU2001237254A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200000375 2000-03-08
DKPA200000375 2000-03-08
PCT/DK2001/000150 WO2001066135A1 (en) 2000-03-08 2001-03-08 Lowering serum lipids

Publications (1)

Publication Number Publication Date
AU2001237254A1 true AU2001237254A1 (en) 2001-09-17

Family

ID=8159299

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237254A Abandoned AU2001237254A1 (en) 2000-03-08 2001-03-08 Lowering serum lipids

Country Status (7)

Country Link
EP (2) EP1263458B1 (en)
JP (1) JP2003525908A (en)
AT (1) ATE309818T1 (en)
AU (1) AU2001237254A1 (en)
DE (1) DE60114996T2 (en)
ES (1) ES2253353T3 (en)
WO (1) WO2001066135A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6323001A (en) 2000-05-19 2001-12-03 Bionebraska Inc Treatment of acute coronary syndrome with glp-1
ATE419863T1 (en) 2001-09-24 2009-01-15 Imp Innovations Ltd PYY3-36 FOR REDUCING OR PREVENTING OBESITY
EP1461070B1 (en) * 2001-12-29 2007-01-24 Novo Nordisk A/S Combined use of a glp-1 compound and an aldose reductase inhibitor
EP1461069A2 (en) 2001-12-29 2004-09-29 Novo Nordisk A/S Combined use of a glp-1 compound and another drug for treating dyslipidemia
WO2003057235A2 (en) 2002-01-10 2003-07-17 Imperial College Innovations Ltd Modification of feeding behavior
AU2003226913A1 (en) * 2002-04-04 2003-10-20 Novo Nordisk A/S Glp-1 agonist and cardiovascular complications
EP1688148A1 (en) * 2002-12-03 2006-08-09 Novo Nordisk A/S Combination treatment using exendin-4 and thiazolidinediones
EP1569682A2 (en) * 2002-12-03 2005-09-07 Novo Nordisk A/S Combination treatment using exendin-4 and thiazolidinediones
GB0300571D0 (en) 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
US20060228331A1 (en) 2003-10-10 2006-10-12 Novo Nordisk A/S IL-21 Derivatives and variants
EP1767545B1 (en) 2005-09-22 2009-11-11 Biocompatibles UK Limited GLP-1 (Glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance
EP1854455B1 (en) 2006-05-10 2009-10-07 Biocompatibles UK Limited Spherical microcapsules comprising GLP-1 peptides, their production and use
ES2376396T3 (en) 2006-06-26 2012-03-13 Amgen Inc. METHOD TO TREAT ATEROSCLEROSIS.
WO2008019143A2 (en) * 2006-08-04 2008-02-14 Amylin Pharmaceuticals, Inc Use of exendins and glp-i receptor agonists for altering lipoprotein particle size and subclass composition
TWI428346B (en) 2006-12-13 2014-03-01 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
AR064623A1 (en) * 2006-12-21 2009-04-15 Centocor Inc USE OF LONG-TERM GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES
EP2163243A1 (en) * 2008-09-12 2010-03-17 Biocompatibles UK Limited Treatment of acute myocardial infarction (AMI) using encapsulated cells encoding and secreting GLP-1 peptides or analogs thereof
EP2664374A1 (en) * 2012-05-15 2013-11-20 F. Hoffmann-La Roche AG Lysin-glutamic acid dipeptide derivatives

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE110083T1 (en) 1986-05-05 1994-09-15 Gen Hospital Corp INSULINOTROPIC HORMONE.
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
WO1990011296A1 (en) 1989-03-20 1990-10-04 The General Hospital Corporation Insulinotropic hormone
ATE164852T1 (en) 1990-01-24 1998-04-15 Douglas I Buckley GLP-1 ANALOGUE USABLE IN DIABETES TREATMENT
DK36392D0 (en) * 1992-03-19 1992-03-19 Novo Nordisk As USE OF CHEMICAL COMPOUND
DK36492D0 (en) 1992-03-19 1992-03-19 Novo Nordisk As PREPARATION
DK39892D0 (en) 1992-03-25 1992-03-25 Bernard Thorens PEPTIDE
US5424286A (en) 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
US5574008A (en) 1994-08-30 1996-11-12 Eli Lilly And Company Biologically active fragments of glucagon-like insulinotropic peptide
US5512549A (en) 1994-10-18 1996-04-30 Eli Lilly And Company Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
US6767887B1 (en) 1996-06-05 2004-07-27 Roche Diagnostics Gmbh Exendin analogues, processes for their preparation and medicaments containing them
US5885997A (en) 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
EP0923580A1 (en) 1996-07-26 1999-06-23 Dr. Reddy's Research Foundation Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
CA2264243C (en) 1996-08-30 2004-10-05 Novo Nordisk A/S Glp-1 derivatives
CN1190434C (en) 1996-12-31 2005-02-23 雷迪实验室有限公司 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
DE122007000044I2 (en) * 1997-01-07 2011-05-05 Amylin Pharmaceuticals Inc USE OF EXEDINES AND THEIR ANTAGONISTS TO REDUCE FOOD CONSUMPTION
WO1998043658A1 (en) 1997-03-31 1998-10-08 Eli Lilly And Company Glucagon-like peptide-1 analogs
EP0981526B1 (en) 1997-05-02 2004-02-25 Dr. Reddy's Laboratories Ltd. Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
WO1999019313A1 (en) 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
BR9812772A (en) 1997-10-27 2000-10-10 Reddy Research Foundation "unpublished tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them"
DE69803750T2 (en) 1997-12-02 2002-09-12 Reddy S Res Foundation Andhra THIAZOLIDINEDIONE AND OXAZOLIDINEDIONE DERIVATIVES WITH ANTIDIABETIC, HYPOLIPIDEMIC AND ANTI-HYPERTENSIVE PROPERTIES
US6803357B1 (en) * 1998-02-02 2004-10-12 New England Medical Center Hospitals, Inc. Method of regulating glucose metabolism, and reagents related thereto
EP1056774A1 (en) 1998-02-27 2000-12-06 Novo Nordisk A/S N-terminally truncated glp-1 derivatives
AU3247799A (en) 1998-02-27 1999-09-15 Novo Nordisk A/S Glp-1 derivatives of glp-1 and exendin with protracted profile of action
WO1999043706A1 (en) 1998-02-27 1999-09-02 Novo Nordisk A/S Derivatives of glp-1 analogs
ATE466028T1 (en) 1998-02-27 2010-05-15 Novo Nordisk As N-TERMINALLY MODIFIED GLP-1 DERIVATIVES
ATE265224T1 (en) 1998-02-27 2004-05-15 Novo Nordisk As GLP-1 DERIVATIVES WITH A HELIX CONTENT OVER 25 THAT FORM PARTIALLY STRUCTURED MICELLAR-LIKE AGGREGATES
WO2000023451A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
JP2002527502A (en) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ New compounds, their preparation and use
JP2002527516A (en) 1998-10-21 2002-08-27 ノボ ノルディスク アクティーゼルスカブ New compounds, their production and use
WO2000023417A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
WO2000023415A1 (en) 1998-10-21 2000-04-27 Novo Nordisk A/S New compounds, their preparation and use
EP1123279A1 (en) 1998-10-21 2001-08-16 Novo Nordisk A/S New compounds, their preparation and use
WO2000041121A1 (en) 1999-01-07 2000-07-13 Ccrewards.Com Method and arrangement for issuance and management of digital coupons and sales offers
WO2000063191A1 (en) 1999-04-16 2000-10-26 Dr. Reddy's Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
MXPA01010472A (en) 1999-04-16 2002-05-06 Reddy Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them.
AU4465200A (en) 1999-04-16 2000-11-02 Dr. Reddy's Research Foundation Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
CN1348439A (en) 1999-04-20 2002-05-08 诺沃挪第克公司 New compounds, their preparation and use
WO2000063196A1 (en) 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
JP2002542237A (en) 1999-04-20 2002-12-10 ノボ ノルディスク アクティーゼルスカブ New compounds, their production and use
WO2000063209A1 (en) 1999-04-20 2000-10-26 Novo Nordisk A/S New compounds, their preparation and use
JP2002544127A (en) * 1999-04-30 2002-12-24 アミリン・ファーマシューティカルズ，インコーポレイテッド Modified exendins and exendin agonists
WO2001035988A1 (en) * 1999-11-12 2001-05-25 Novo Nordisk A/S Use of glp-1 agonists for the inhibition of beta cell degeneration
ES2227115T5 (en) * 2000-01-10 2014-10-30 Amylin Pharmaceuticals, Inc. Use of exendins and their agonists for the treatment of hypertriglyceridemia

Also Published As

Publication number Publication date
EP1634605A3 (en) 2006-10-11
JP2003525908A (en) 2003-09-02
DE60114996D1 (en) 2005-12-22
ATE309818T1 (en) 2005-12-15
WO2001066135A1 (en) 2001-09-13
EP1263458A1 (en) 2002-12-11
EP1634605A2 (en) 2006-03-15
EP1263458B1 (en) 2005-11-16
ES2253353T3 (en) 2006-06-01
DE60114996T2 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
AU2001237254A1 (en) Lowering serum lipids
AU2001283270A1 (en) Method and apparatus for providing group calls via the internet
AU2001231104A1 (en) Methods for treating diabetes
AU5469701A (en) Surface, method for the production thereof and an object provided with said surface
AU2001238369A1 (en) Method for treating thyroid disorders
ZA99104B (en) Method for administering ASPB28-human insulin.
AU2002210234A1 (en) Method for transmitting short messages over the internet
AU2001251239A1 (en) Individual xml message processing platform
AU2002351178A1 (en) A method for expressing emotion in a text message
AU2002213975A1 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
MXPA03001890A (en) Polyarylcarboxamides useful as lipid lowering agents.
AU2002232386A1 (en) A method for testing a light-emitting panel and the components therein
SG108272A1 (en) Method for translucent online interaction
AU2001276295A1 (en) Electric component, method for the production thereof, and its use
AU6004101A (en) Method for fabricating silicon-on-insulator
AU4864801A (en) Method for assembling text messages
AU2002223690A1 (en) Method for producing an organic solvent-free lycopene concentrate, the resulting concentrate and composition comprising said concentrate
AU2001263835A1 (en) Haemostatically active preparation containing vWF and method for the production thereof
AU1479101A (en) A system and method for replaying a predefined path through the internet
AU2094401A (en) Automated bindery log extension
AU2001272808A1 (en) The consignment sale method using internet
AU2002221131A1 (en) Blood lipid ameliorant composition
AU2001287143A1 (en) Method and system for assembling concurrently-generated content
AU2001289695A1 (en) Impregnate, method for the production and use thereof
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them